Searching News Database: facioscapulohumeral muscular dystrophy
HSMN NewsFeed - 3 Apr 2017
aTyr Pharma Announces Appointment of Jeffery S. Hatfield to its Board of Directors
aTyr Pharma Announces Appointment of Jeffery S. Hatfield to its Board of Directors
HSMN NewsFeed - 5 May 2016
aTyr Pharma Appoints Grove Matsuoka as Senior Vice President, Product Programs and Planning
aTyr Pharma Appoints Grove Matsuoka as Senior Vice President, Product Programs and Planning
HSMN NewsFeed - 18 Feb 2015
aTyr Pharma Receives EMA Orphan Drug Designation for Resolaris(TM) in FSHD
aTyr Pharma Receives EMA Orphan Drug Designation for Resolaris(TM) in FSHD